KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) FCF Margin (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed FCF Margin for 17 consecutive years, with 17.18% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 500.0% to 17.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14.5% through Dec 2025, up 322.0% year-over-year, with the annual reading at 14.5% for FY2025, 322.0% up from the prior year.
  • FCF Margin for Q4 2025 was 17.18% at Bio-Rad Laboratories, up from 13.66% in the prior quarter.
  • The five-year high for FCF Margin was 26.2% in Q3 2021, with the low at 2.44% in Q3 2022.
  • Average FCF Margin over 5 years is 11.0%, with a median of 10.09% recorded in 2023.
  • The sharpest move saw FCF Margin tumbled -2864bps in 2022, then surged 1147bps in 2025.
  • Over 5 years, FCF Margin stood at 15.66% in 2021, then tumbled by -61bps to 6.13% in 2022, then dropped by -7bps to 5.69% in 2023, then soared by 114bps to 12.18% in 2024, then skyrocketed by 41bps to 17.18% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 17.18%, 13.66%, and 10.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.